Johnson & Johnson scraps Alzheimer's trials on safety concerns

(Reuters) - Johnson and Johnson said it would stop mid-stage trials testing its experimental Alzheimer's drug after observing safety issues, the latest drugmaker to abandon developing treatments for the memory-robbing disease.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Alzheimer's | Health